Litigation Details for RHODES PHARMACEUTICALS L.P. v. ACTAVIS, INC. (D.N.J. 2016)
✉ Email this page to a colleague
RHODES PHARMACEUTICALS L.P. v. ACTAVIS, INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-03-25 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-04-17 |
| Cause | 35:271 Patent Infringement | Assigned To | William H. Walls |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | RHODES PHARMACEUTICALS L.P. | ||
| Patents | 6,419,960; 7,083,808; 7,247,318; 7,438,930; 8,580,310; 9,066,869 | ||
| Attorneys | WILLIAM C. BATON | ||
| Firms | Steptoe and Johnson LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in RHODES PHARMACEUTICALS L.P. v. ACTAVIS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for RHODES PHARMACEUTICALS L.P. v. ACTAVIS, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-10-21 | 57 | ”) concerns a patent dispute relating to U.S. Patent Nos. 6,419,960 (“the ‘960 patent”), 7,083,808 …: 863 ‘31$ patent”), 8,580,310 (“the ‘310 patent”), 7,438,930 (“the ‘930 Patent”) and 9,066,869 …prosecuting any patent application, continuation, or divisional patent application, reissue patent application…9,066,869 (“the ‘869 patent”) (collectively, “the patents-in-suit”). In light of the nature of the…Engaging, directly or indirectly, in any patent prosecution of any patent application that: (1) includes | External link to document | |
| 2017-03-14 | 74 | Covenant Not to Sue for Infringement of U.S. Patent No. 7,438,930 by RHODES PHARMACEUTICALS L.P.. (Attachments…2016 17 April 2018 2:16-cv-01668 830 Patent None District Court, D. New Jersey | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
